Table 1.
Baseline characteristics and surgical details of the prehabilitation and control groups
| Prehabilitation group (n = 11) | Control group (n = 11) | p value | |
|---|---|---|---|
| Age (years) | 55.5 (49.2, 61.7) | 61.0 (53.1, 68.9) | 0.223 |
| Age ≥ 65 years | 1 (9%) | 4 (36%) | |
| Sex ratio (male:female) | 4:7 | 7:4 | |
| BMI (kg/m2) | 30.0 (25.6, 34.4) | 27.8 (23.4, 32.2) | 0.442 |
| ECOG performance status | |||
| 0 | 9 (82%) | 10 (91%) | |
| 1 | 2 (18%) | 1 (9%) | |
| 2–4 | 0 (0%) | 0 (0%) | |
| Primary diagnosis | |||
| Colorectal adenocarcinoma | 7 (64%) | 8 (73%) | |
| Pseudomyxoma peritonei | 3 (27%) | 1 (9%) | |
| Other | 1 (9%) | 2 (18%) | |
| Type of surgery | |||
| CRS and HIPEC | 9 (82%) | 7 (64%) | |
| AP resection | 0 (0%) | 2 (18%) | |
| Total pelvic clearance | 1 (9%) | 1 (9%) | |
| Right hemicolectomy + cystectomy | 0 (0%) | 1 (9%) | |
| Laparotomy + small bowel resection | 1 (9%) | 0 (0%) | |
| Length of time from study appointment to surgery (days) | 30.5 (18.7, 42.2) | 20.8 (12.7, 29.0) | 0.072 |
Data are expressed as mean (95% CI), n (%), or male:female
AP abdominoperineal, BMI body mass index, CRS with HIPEC cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, ECOG Eastern Cooperative Group